Q3 2017 13F Holders as of 30 Sep 2017
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
8,564,500
-
Number of holders
-
80
-
Total 13F shares, excl. options
-
26,588,544
-
Shares change
-
+846,343
-
Total reported value, excl. options
-
$441,130,415
-
Value change
-
+$15,294,795
-
Put/Call ratio
-
1.1%
-
Number of buys
-
37
-
Number of sells
-
-31
-
Price
-
$16.55
Significant Holders of Atara Biotherapeutics, Inc. - Common Stock (ATRA) as of Q3 2017
96 filings reported holding ATRA - Atara Biotherapeutics, Inc. - Common Stock as of Q3 2017.
Atara Biotherapeutics, Inc. - Common Stock (ATRA) has 80 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 26,588,544 shares
.
Largest 10 shareholders include BAUPOST GROUP LLC/MA (5,359,632 shares), Redmile Group, LLC (2,889,710 shares), ArrowMark Colorado Holdings LLC (2,775,721 shares), BlackRock Inc. (1,992,643 shares), FMR LLC (1,803,168 shares), BRIDGER MANAGEMENT, LLC (1,652,513 shares), EAGLE ASSET MANAGEMENT INC (1,490,076 shares), MORGAN STANLEY (1,437,661 shares), Neuberger Berman Group LLC (1,115,041 shares), and VANGUARD GROUP INC (918,150 shares).
This table shows the top 80 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.